Products for Research Use Only
RegisterLogin

Hu7691

CAT: 0804-HY-132302-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-132302-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Hu7691 is an orally active, selective Akt inhibitor with IC50s of 4.0 nM, 97.5 nM, 28 nM for Akt1, Akt2 and Akt3, respectively. Hu7691 inhibits tumor growth and enables decrease of cutaneous toxicity in mice[1].
CAS Number
2360523-76-6
UNSPSC
12352005
Target
Akt; PKA; PKC; Ribosomal S6 Kinase (RSK) ; ROCK; SGK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; MAPK/ERK Pathway; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hu7691.html
Purity
99.91
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N[C@@H]1CNCC[C@H]1C2=CC=C(F)C(F)=C2)C3=CC=C(C4=CC=NN4C)C=C3F.[H]Cl
Molecular Formula
C22H22ClF3N4O
Molecular Weight
450.88
References & Citations
[1]Jinxin Che, et al. Discovery of N- ((3 S,4 S) -4- (3,4-Difluorophenyl) piperidin-3-yl) -2-fluoro-4- (1-methyl-1 H-pyrazol-5-yl) benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity. J Med Chem. 2021 Aug 26;64 (16) :12163-12180.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Akt1; Akt2; Akt3; p70S6K; PKA; PKCη; ROCK1

Alternative Products

CatalogName
T39899-01Hu7691
T39733-01Hu7691 free base

Popular Products